So far, large federal studies have shown no higher risk for major birth defects, miscarriage or other complications.

The Food and Drug Administration (FDA) has approved Bosaya ™ (denosumab-kyqq) and Aukelso ™ (denosumab-kyqq), biosimilars to Prolia ® (denosumab) and Xgeva ® (denosumab), respectively.

Garetosmab is a fully-human monoclonal antibody designed to bind and neutralize Activin A, a major promoter of HO in patients with FOP.

Findings show discomfort primarily exists among gynecologists seeing patients with a history of endometrial or epithelial ovarian cancer ...

The ACHIEVE-3 trial was a 52-week, randomized, open-label study that included 1698 T2D patients inadequately controlled on metformin.

US Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. has said he plans to appoint as many as 7 new members. In June, Kennedy removed all 17 members of the panel, claiming it had ...

Anifrolumab, a type I interferon receptor antagonist, is currently approved under the brand name Saphnelo for IV administration in the treatment of moderate to severe SLE.

Factors tied to discontinuation included younger age, male sex, socioeconomic deprivation, higher comorbidity level.

The Womed Leaf consists of a proprietary polymer that is inserted into the uterine cavity immediately after completion of a hysteroscopic adhesiolysis procedure.

HealthDay News — Consuming high levels of ultraprocessed foods is associated with increased levels of high-sensitivity C-reactive protein (hsCRP), according to a study published online September 3 in ...

HealthDay News — A child in Los Angeles County has died from a rare brain disorder caused by a measles infection in infancy, health officials reported.

HealthDay News — Cessation of Ryan White services, which provide care for more than half of people with HIV in the US, could yield an increase in HIV incidence, according to a study published online ...